
Pharmaceuticals & Chemicals · BSE
Incorporated in 2008, Sudarshan Pharma Industries Limited (SPIL) is a Mumbai-based company engaged in contract manufacturing, import, export, and supply of specialty chemicals, Active Pharmaceutical Ingredients (APIs), and intermediates. The company sources and supplies generic formulations by outsourcing manufacturing facilities from domestic and international suppliers based on client requirements. Its products find applications across industries such as pharmaceuticals, paints, food, and adhesives. SPIL also supplies medicines and pharma formulations to hospitals, NGOs, government bodies, and healthcare institutions under its own brand, offering around 50 formulations in tablets, capsules, ointments, and injectables. With a strong sales and distribution network across five states, the company markets its products ethically in both Indian and international markets, while also offering formulation development, quality control, and customized pharma solutions.
Price Band
₹71 – ₹73
Issue Size
₹50.10 Cr
Lot Size
1600 shares
GMP
Est. Listing
₹73
at current GMP
Subscribed
1.06x
overall
Open
9 Mar 2023
Close
14 Mar 2023
Allotment
18 Mar 2023
Refund
19 Mar 2023
Demat Credit
20 Mar 2023
Listing
20 Mar 2023
Overall Subscription
1.06x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.00x
High Net-Worth
Retail (RII)
0.00x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| Qualified Institutional (QIB) | 3,431,507 | — | 0.00x |
| Non-Institutional (NII / HNI) | 1,029,452 | — | 0.00x |
| Retail Individual (RII) | 2,402,055 | — | 0.00x |
| Total | 6,863,014 | 0 | 1.06x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 1,501 | 1,591 | 1.06x |
| HNIs (10L +) | 10 | 11 | 1.10x |
| HNIs (2-10L) | 46 | 49 | 1.07x |
| Total Applications | 1,557 | 1,651 | 1.06x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Sudarshan Pharma Industries Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Chemicals sector with an aggregate issue size of ₹50.1 Crores. The shares are offered at a price band of ₹71 to ₹73 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1600 shares (approx. ₹1,16,800 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-03-20, while un-allotted funds or UPI block mandates will be released on 2023-03-19.
Currently, Sudarshan Pharma Industries Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹71 to ₹73 per equity share.
The retail lot size is 1600 shares requiring a minimum application amount of ₹1,16,800. Expected listing price is ₹73 per equity share.
The Sudarshan Pharma Industries Limited IPO aggregate issue size is ₹50.1 Crores with an equity price band set at ₹71 to ₹73 per equity share. The retail lot size is 1600 shares requiring a minimum capital outlay of approx. ₹1,16,800.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 1.06x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2023-03-18. Investors can verify status using PAN card or application number.
Sudarshan Pharma Industries Limited shares are scheduled to list on BSE on 2023-03-20.